244 related articles for article (PubMed ID: 18480940)
21. Infliximab treatment and pregnancy outcome in active Crohn's disease.
Srinivasan R
Am J Gastroenterol; 2001 Jul; 96(7):2274-5. PubMed ID: 11467677
[No Abstract] [Full Text] [Related]
22. [Early obstructive colon after treatment of active refractory Crohn's disease with infliximab].
Belaiche J; Louis E
Gastroenterol Clin Biol; 2003 Nov; 27(11):1045-7. PubMed ID: 14732856
[No Abstract] [Full Text] [Related]
23. Transient type III atrioventricular block after infliximab infusion in a fistulizing perianal Crohn's disease patient.
Sofos S; Savoye G; Ramirez S; Bauer F; Lerebours E
Am J Gastroenterol; 2007 Jan; 102(1):217-9. PubMed ID: 17278277
[No Abstract] [Full Text] [Related]
24. Immunogenicity of infliximab in Crohn's disease.
Hanauer SB
N Engl J Med; 2003 May; 348(21):2155-6; author reply 2155-6. PubMed ID: 12761378
[No Abstract] [Full Text] [Related]
25. Does administration of infliximab increase susceptibility to listeriosis?
Morelli J; Wilson FA
Am J Gastroenterol; 2000 Mar; 95(3):841-2. PubMed ID: 10710107
[No Abstract] [Full Text] [Related]
26. Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions.
Duburque C; Lelong J; Iacob R; Seddik M; Desreumaux P; Fournier C; Wallaert B; Cortot A; Colombel JF
Aliment Pharmacol Ther; 2006 Sep; 24(5):851-8. PubMed ID: 16918890
[TBL] [Abstract][Full Text] [Related]
27. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance.
Francis G; Duggan A
Gastroenterology; 2008 Dec; 135(6):2156-7. PubMed ID: 19013168
[No Abstract] [Full Text] [Related]
28. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
Martínez F; Nos P; Benlloch S; Ponce J
Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy with infliximab and immunomodulators: is the glass half empty?
Deshpande AR; Abreu MT
Gastroenterology; 2008 Jun; 134(7):2161-3. PubMed ID: 18482585
[No Abstract] [Full Text] [Related]
30. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
[No Abstract] [Full Text] [Related]
31. [Fulminant acute hepatitis B after infliximab treatment in Crohn's disease].
Olfa H; Aroua G; Wissem M; Wafa BM; Hichem L; Nabil BC; Fethia B; Leila S
Tunis Med; 2014 May; 92(5):349-50. PubMed ID: 25504398
[No Abstract] [Full Text] [Related]
32. Monoclonal antibody therapy for Crohn's disease.
Selby W
Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
[No Abstract] [Full Text] [Related]
33. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
Abdelmalek MF; Liu C; Valentine JF
Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
[No Abstract] [Full Text] [Related]
34. Generalized pustular psoriasis triggered by infliximab in two patients with Crohn's disease.
Kato Y; Yamamoto T
J Dermatol; 2013 Nov; 40(11):932-3. PubMed ID: 24127642
[No Abstract] [Full Text] [Related]
35. Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize.
Sandborn WJ
Gastroenterology; 2003 Apr; 124(4):1140-5. PubMed ID: 12671907
[No Abstract] [Full Text] [Related]
36. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
Gisbert JP; Panés J
Am J Gastroenterol; 2009 Mar; 104(3):760-7. PubMed ID: 19174781
[TBL] [Abstract][Full Text] [Related]
37. Infliximab treatment of postoperative ulcers in Crohn's disease: to inject or not to inject--that is the question.
Blonski W; Lichtenstein GR
Gastrointest Endosc; 2006 Mar; 63(3):493-6. PubMed ID: 16500403
[No Abstract] [Full Text] [Related]
38. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
[TBL] [Abstract][Full Text] [Related]
39. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
[TBL] [Abstract][Full Text] [Related]
40. Use of infliximab in the treatment of Crohn's disease in children and adolescents.
Hyams JS
J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S36-9. PubMed ID: 11685974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
